|
Health Management Associates, Inc.
May 8, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Naples, Florida-based Health Management Associates, Inc. (“Health Management” or “Company”) (NYSE: HMA) for potential violations of the federal securities laws. Investors who purchased Health Management’s common stock may be affected.
|
|
IEC Electronics, Corp.
May 8, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Newark, New York-based IEC Electronics Corp. (“IEC” or the “Company”) (NYSE: IEC) for potential violations of the federal securities laws. Investors who purchased IEC common stock from February 8, 2012 through May 1, 2013 may be affected.
|
|
UniTek Global Services, Inc.
May 7, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Blue Bell, Pennsylvania-based UniTek Global Services, Inc. (“UniTek” or the “Company”) (Nasdaq: UNTK) for potential violations of the federal securities laws. Investors who purchased UniTek common stock between May 18, 2011 and April 12, 2013 may be affected.
|
|
Ixia
April 9, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Calabasas, California-based Ixia (“Company”) (Nasdaq: XXIA) for potential violations of the federal securities laws. Investors who purchased Ixia common stock may be affected.
|
|
American Greetings Corporation
April 8, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating the announcement of American Greetings Corporation (“American Greetings” or the “Company”) that it has entered an agreement to be taken private by a group led by Chief Executive Officer Zev Weiss. According to the Company the total value of the transaction is approximately $878 million, including the assumption of certain notes. Kaplan Fox is investigating whether the agreement to be taken private unreasonably limits prospective bids for American Greetings.
|
|
Star Scientific, Inc.
March 26, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Glen Allen, Virginia-based Star Scientific, Inc. (“Star Scientific” or the “Company”) (Nasdaq: STSI) for potential violations of the federal securities laws. Investors who purchased Star Scientific common stock may be affected.
|
|
John Thomas Bridge and Opportunity Fund LP I and II
March 25, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating the John Thomas Bridge and Opportunity Fund LP I and John Thomas Bridge and Opportunity Fund LP II (“the Funds”), John Thomas Financial, Inc. (“John Thomas Financial”), John Thomas Capital Management Group LLC (“John Thomas Capital Management”), George R. Jarkesy Jr. (“Jarkesy”), and Anastasios “Tommy” Belesis (“Belesis”) for potential violations of the federal securities laws based on a complaint filed by the Securities and Exchange Commission (“SEC”).
|
|
Tech Data Corp.
March 22, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Clearwater, Florida-based Tech Data Corp. (“Tech Data” or the “Company”) (Nasdaq: TECD) for potential violations of the federal securities laws. Investors who purchased Tech Data common stock between May 21, 2010 and March 21, 2013 may be affected.
|
|
Harvest Natural Resources, Inc.
March 19, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Harvest Natural Resources Inc. (Symbol: HNR) (“HNR” or the “Company”)) for potential violations of the federal securities laws. According to the Associated Press, lost nearly half of its market value after the start of trading on March 19, 2013 after the oil and gas producer said it identified some accounting errors that might force it to restate results for some periods in the last three years.
|
|
Great Lakes Dredge & Dock Corp.
March 15, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Great Lakes Dredge & Dock Corp. (Symbol: GLDD) for potential violations of the federal securities laws. According to the Associated Press, shares of Great Lakes Dredge & Dock Corp. plunged in after-hours trading after the company said it will restate its second- and third-quarter results because of problems with the way it recorded revenue. It also announced the departure of its president and chief operating officer.
|
|
Accretive Health, Inc.
February 27, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Accretive Health, Inc. (AH), a provider of “revenue cycle and quality of care services to healthcare providers” concerning its announcement that it will postpone the release of its financial results for the fourth quarter and full year 2012, as well as its previously announced investor conference call scheduled for February 27, 2013, because it is “evaluating the timing of revenue recognition for its revenue cycle management agreements."
|
|
SciClone Pharmaceuticals, Inc.
February 26, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Foster City, California-based SciClone Pharmaceuticals, Inc. (“SciClone” or the “Company”) (Nasdaq: SCLN) for potential violations of the federal securities laws. Investors who purchased SciClone common stock may be affected.
|
|
Ebix, Inc.
February 22, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Atlanta, Georgia-based Ebix Inc. (“Ebix” or the “Company”) (Nasdaq: EBIX) for potential violations of the federal securities laws. Investors who purchased EBIX common stock may be affected.
|
|
Accuray, Inc.
January 4, 2013 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Sunnyvale, California-based Accuray Incorporated (“Accuray” or the “Company”) (Nasdaq: ARAY) for potential violations of the federal securities laws. Investors who purchased Company securities may be affected.
|
|
Crestor® (rosuvastatin calcium)
May 25, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating the statin drug Crestor® (rosuvastatin), a cholesterol-lowering medication, approved by the Food and Drug Administration for use by the public in August 2003.
|
|
Global Payments, Inc.
April 10, 2012 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Atlanta, Georgia-based Global Payments Inc.. (“Global Payments” or “Company”) (NYSE: GPN) for potential violations of the federal securities laws. Investors who purchased the Company’s common stock may be affected.
|
Case Investigations